Anavex Life Sciences Corp. Company Profile (NASDAQ:AVXL)

About Anavex Life Sciences Corp.

Anavex Life Sciences Corp. logoAnavex Life Sciences Corp., is a clinical-stage biopharmaceutical company engaged in the development of drug candidates. The Company's lead compounds include ANAVEX 2-73, ANAVEX PLUS, a combination of ANAVEX 2-73 with donepezil (Aricept), ANAVEX 19-144, ANAVEX 1-41, ANAVEX 7-1037, ANAVEX 3-71, ANAVEX 1079, ANAVEX 1519 and ANAVEX 1066 being developed to treat Alzheimer's disease and other central nervous system (CNS) diseases. The Company's SIGMACEPTOR Discovery Platform produced small molecule drug candidates with unique modes of action. Sigma receptors may be targets for therapeutics to combat many human diseases, including Alzheimer's disease. When bound by the appropriate ligands, sigma receptors influence the functioning of multiple biochemical signals that are involved in the pathogenesis (origin or development) of disease.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: AVXL
  • CUSIP:
Key Metrics:
  • Previous Close: $5.44
  • 50 Day Moving Average: $4.61
  • 200 Day Moving Average: $3.68
  • 52-Week Range: $41,073,000.00 - $2.43
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -9.23
  • P/E Growth: 0.00
  • Market Cap: $216.04B
  • Outstanding Shares: 41,073,000
  • Beta: -0.27
Profitability:
  • Return on Equity: -131.78%
  • Return on Assets: -106.85%
Debt:
  • Current Ratio: 9.74%
  • Quick Ratio: 9.74%
Additional Links:
Companies Related to Anavex Life Sciences Corp.:

Analyst Ratings

Consensus Ratings for Anavex Life Sciences Corp. (NASDAQ:AVXL) (?)
Ratings Breakdown: 3 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $13.67 (159.82% upside)

Analysts' Ratings History for Anavex Life Sciences Corp. (NASDAQ:AVXL)
Show:
DateFirmActionRatingPrice TargetDetails
2/7/2017Noble FinancialInitiated CoverageBuy$16.00View Rating Details
1/19/2017Maxim GroupSet Price TargetBuy$15.00View Rating Details
10/5/2016FBR & CoReiterated RatingOutperform$10.00View Rating Details
(Data available from 2/20/2015 forward)

Earnings

Earnings History for Anavex Life Sciences Corp. (NASDAQ:AVXL)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/9/2017        
8/11/2016Q316($0.09)($0.06)ViewN/AView Earnings Details
5/11/2016Q2($0.16)($0.06)ViewN/AView Earnings Details
2/8/2016Q116($0.12)ViewN/AView Earnings Details
12/29/2015Q4($0.06)($0.65)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Anavex Life Sciences Corp. (NASDAQ:AVXL)
Current Year EPS Consensus Estimate: $-0.34 EPS
Next Year EPS Consensus Estimate: $-0.57 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.14)($0.14)($0.14)
Q2 20161($0.14)($0.14)($0.14)
Q3 20161($0.09)($0.09)($0.09)
Q4 20161($0.08)($0.08)($0.08)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Anavex Life Sciences Corp. (NASDAQ:AVXL)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Anavex Life Sciences Corp. (NASDAQ:AVXL)
Insider Ownership Percentage: 9.37%
Institutional Ownership Percentage: 11.59%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/14/2015Christopher U MisslingCEOBuy1,000$0.52$520.00View SEC Filing  
7/13/2015Christopher U MisslingCEOBuy1,000$0.53$530.00View SEC Filing  
7/7/2015Christopher U MisslingCEOBuy2,000$0.49$980.00View SEC Filing  
7/1/2015Christopher U MisslingCEOBuy2,000$0.45$900.00View SEC Filing  
6/23/2015Christopher U MisslingCEOBuy1,000$0.47$470.00View SEC Filing  
6/22/2015Christopher U MisslingCEOBuy1,000$0.42$420.00View SEC Filing  
6/16/2015Christopher U MisslingCEOBuy1,000$0.44$440.00View SEC Filing  
6/15/2015Christopher U MisslingCEOBuy1,000$0.43$430.00View SEC Filing  
6/10/2015Christopher U MisslingCEOBuy1,000$0.36$360.00View SEC Filing  
6/8/2015Christopher U MisslingCEOBuy1,000$0.35$350.00View SEC Filing  
6/4/2015Christopher U MisslingCEOBuy1,000$0.37$370.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Anavex Life Sciences Corp. (NASDAQ:AVXL)
DateHeadline
News IconAnavex Life Sciences Corp. (AVXL): The Technicals As Seen Today - NY Stock News (NASDAQ:AVXL)
nystocknews.com - February 19 at 9:31 AM
News IconAnavex Life Sciences Institutional Traders Accumulating (NASDAQ:AVXL)
www.guerillastocktrading.com - February 16 at 8:51 PM
News IconAnavex Life Sciences Institutional Traders Accumulating (NASDAQ:AVXL)
www.guerillastocktrading.com - February 16 at 8:51 PM
News IconTrader Alert: Unusual Volume Spotted in Anavex Life Sciences Corp ... - Winfield Review (NASDAQ:AVXL)
winfieldreview.com - February 16 at 3:49 PM
istreetwire.com logoEye Catching Stocks: Axalta Coating Systems Ltd. (AXTA), Anavex Life Sciences Corp. (AVXL), Gigamon Inc. (GIMO) - iStreetWire (NASDAQ:AVXL)
istreetwire.com - February 16 at 3:49 PM
News IconAnavex Life Sciences Corp. :AVXL Sees Unusual Volatility in ... - Aiken Advocate (NASDAQ:AVXL)
aikenadvocate.com - February 16 at 3:49 PM
News IconImpact of Brokerage Rating on Anavex Life Sciences Corp.(AVXL) (NASDAQ:AVXL)
ekosvoice.com - February 16 at 8:39 AM
News IconAnavex Life Sciences Corp. (NASDAQ:AVXL) Upside Stock Technicals at Extreme Strength (NASDAQ:AVXL)
eleganthomesinla.com - February 16 at 8:39 AM
News IconStock Price of Anavex Life Sciences Corp. (AVXL) Increases 19.92% (NASDAQ:AVXL)
hoyentv.com - February 16 at 8:39 AM
News IconRevenue Update on Anavex Life Sciences Corp.(NASDAQ:AVXL) (NASDAQ:AVXL)
www.graffiotech.com - February 14 at 4:25 PM
streetinsider.com logoAnavex Life Sciences (AVXL) Appoints Peter Donhauser to Board of Directors (NASDAQ:AVXL)
www.streetinsider.com - February 13 at 4:16 PM
finance.yahoo.com logoAnavex Life Sciences Strengthens Board of Directors (NASDAQ:AVXL)
finance.yahoo.com - February 13 at 4:16 PM
globenewswire.com logoAnavex Life Sciences' CEO Joins BIO CEO & Investor Conference 2017 Panel “Designing Clinical Trials in 21st ... - GlobeNewswire (press release) (NASDAQ:AVXL)
globenewswire.com - February 9 at 3:54 PM
finance.yahoo.com logoAnavex Life Sciences’ CEO Joins BIO CEO & Investor Conference 2017 Panel “Designing Clinical Trials in 21st Century Cures Paradigm” (NASDAQ:AVXL)
finance.yahoo.com - February 9 at 3:54 PM
News IconAnavex Life Sciences Corp. (NASDAQ:AVXL) Continues To Run Against The Crowd - Insider Financial (NASDAQ:AVXL)
www.insiderfinancial.com - February 8 at 8:42 PM
News IconAnavex Life Sciences Corp. (:AVXL) RSI Hits Key Level - Aiken Advocate (NASDAQ:AVXL)
aikenadvocate.com - February 8 at 3:38 PM
istreetwire.com logoStocks To Track: Square, Inc. (SQ), Anavex Life Sciences Corp. (AVXL), HD Supply Holdings, Inc. (HDS) - iStreetWire (NASDAQ:AVXL)
istreetwire.com - February 8 at 3:38 PM
fool.com logoHere's Why Anavex Life Sciences Corp. Surged Today - Motley Fool (NASDAQ:AVXL)
www.fool.com - February 8 at 3:38 PM
biz.yahoo.com logoANAVEX LIFE SCIENCES CORP. Files SEC form 10-Q, Quarterly Report (NASDAQ:AVXL)
biz.yahoo.com - February 8 at 3:38 PM
us.rd.yahoo.com logoAnavex Reports Fiscal First Quarter 2017 Financial Results (NASDAQ:AVXL)
us.rd.yahoo.com - February 7 at 4:41 PM
sg.finance.yahoo.com logoAnavex Life Sciences reports 1Q loss (NASDAQ:AVXL)
sg.finance.yahoo.com - February 7 at 4:41 PM
finance.yahoo.com logoNoble Capital Markets Initiates Research Coverage on Anavex Life Sciences Corp. (AVXL) (NASDAQ:AVXL)
finance.yahoo.com - February 7 at 4:41 PM
finance.yahoo.com logoCoverage initiated on Anavex by Noble Financial (NASDAQ:AVXL)
finance.yahoo.com - February 7 at 4:41 PM
fool.com logoHere's Why Anavex Life Sciences Corp. Surged Today (NASDAQ:AVXL)
www.fool.com - February 7 at 4:41 PM
fool.com logoHere's Why Anavex Life Sciences Corp. Surged Today (NASDAQ:AVXL)
www.fool.com - February 7 at 2:13 PM
News IconErratic Volume Stretches This Stock Mid-Session: Anavex Life Sciences Corp. (:AVXL) - Davidson Register (NASDAQ:AVXL)
davidsonregister.com - February 6 at 3:47 PM
News IconCorralling Gains for Investors As Shares Pop: Anavex Life Sciences Corp. (:AVXL) - Aiken Advocate (NASDAQ:AVXL)
aikenadvocate.com - February 6 at 3:47 PM
fool.com logoForget Anavex Life Sciences Corp.: These 2 Biotech Stocks Are Better Buys - Motley Fool (NASDAQ:AVXL)
www.fool.com - February 1 at 3:55 PM
fool.com logoForget Anavex Life Sciences Corp.: These 2 Biotech Stocks Are Better Buys (NASDAQ:AVXL)
www.fool.com - February 1 at 11:40 AM
News IconTicker Tracker: Looking at Anavex Life Sciences Corp. (AVXL) - Rives Journal (NASDAQ:AVXL)
rivesjournal.com - January 28 at 8:46 PM
News IconWilliams %R, RSI, and ADX Update for Anavex Life Sciences Corp. (AVXL) - Sherwood Daily (NASDAQ:AVXL)
sherwooddaily.com - January 26 at 9:13 PM
News IconTechnical Indicator Review on Shares of Anavex Life Sciences Corp. (AVXL) - Sherwood Daily (NASDAQ:AVXL)
sherwooddaily.com - January 24 at 4:15 PM
News IconAnavex Life Sciences to Present at Noble Capital Markets Thirteenth Annual Investor Conference - EconoTimes (NASDAQ:AVXL)
www.econotimes.com - January 23 at 8:51 PM
News IconUpside Alert: Delving into Shares of Anavex Life Sciences Corp. (:AVXL) - Prospect Journal (NASDAQ:AVXL)
prospectjournal.com - January 23 at 8:51 PM
finance.yahoo.com logoAnavex Life Sciences to Present at Noble Capital Markets’ Thirteenth Annual Investor Conference (NASDAQ:AVXL)
finance.yahoo.com - January 23 at 3:49 PM
News IconTrump Sworn In as S&P Declined, How Did this Stock Perform This Week: Anavex Life Sciences Corp. (:AVXL) - Aiken Advocate (NASDAQ:AVXL)
aikenadvocate.com - January 22 at 3:43 PM
News IconMarket Corner: Eye on Technicals for Anavex Life Sciences Corp. (AVXL) - Sherwood Daily (NASDAQ:AVXL)
sherwooddaily.com - January 22 at 3:43 PM
News IconMA Watch on Shares of Anavex Life Sciences Corp. (AVXL) - Rives Journal (NASDAQ:AVXL)
rivesjournal.com - January 21 at 3:40 PM
streetinsider.com logoAnavex Life Sciences (AVXL) Receives 600K Grant to Commence Phase 2 Trial in 2017 (NASDAQ:AVXL)
www.streetinsider.com - January 20 at 9:47 PM
nasdaq.com logoNoteworthy Friday Option Activity: BA, TRN, AVXL - Nasdaq (NASDAQ:AVXL)
www.nasdaq.com - January 20 at 4:47 PM
News IconKeeping Tabs on Technicals for Anavex Life Sciences Corp. (AVXL) - Sherwood Daily (NASDAQ:AVXL)
sherwooddaily.com - January 20 at 2:58 AM
streetinsider.com logoAnavex Life Sciences (AVXL) Receives 600K Grant to Commence Phase 2 Trial in 2017 - StreetInsider.com (NASDAQ:AVXL)
www.streetinsider.com - January 20 at 2:58 AM
seekingalpha.com logoAnavex nabs grant to fund mid-stage study of lead product candidate in Rett syndrome; shares ahead 4% premarket (NASDAQ:AVXL)
seekingalpha.com - January 19 at 4:52 PM
smarteranalyst.com logoMaxim Analyst Chimes In on Anavex Life Sciences Corp. (AVXL) (NASDAQ:AVXL)
www.smarteranalyst.com - January 19 at 4:52 PM
finance.yahoo.com logoAnavex Life Sciences Receives Grant From Rettsyndrome.org to Commence U.S. Phase 2 Trial in 2017 (NASDAQ:AVXL)
finance.yahoo.com - January 19 at 4:52 PM
marketwatch.com logoAnavex awarded grant to fund clinical trial of Rett syndrome drug (NASDAQ:AVXL)
www.marketwatch.com - January 19 at 4:52 PM
News IconShort Interest Change: Is Buying Anavex Life Sciences Corporation (OTCMKTS:AVXL), Having Higher Short Interest a ... - Baxley Report (NASDAQ:AVXL)
baxleyreport.com - January 18 at 4:24 PM
News IconTechnical Watch on These Shares: Anavex Life Sciences Corp. (AVXL) - Rives Journal (NASDAQ:AVXL)
rivesjournal.com - January 18 at 4:24 PM
News IconAnavex Life Sciences Corp. (AVXL) Stock Down After Price Target ... - BNB Daily (blog) (NASDAQ:AVXL)
www.baseball-news-blog.com - January 15 at 3:41 PM
News IconNotable Friday Option Activity: LJPC, AIG, AVXL (NASDAQ:AVXL)
www.stockoptionschannel.com - January 13 at 4:18 PM

Social

What is Anavex Life Sciences Corp.'s stock symbol?

Anavex Life Sciences Corp. trades on the NASDAQ under the ticker symbol "AVXL."

Where is Anavex Life Sciences Corp.'s stock going? Where will Anavex Life Sciences Corp.'s stock price be in 2017?

3 analysts have issued 1 year target prices for Anavex Life Sciences Corp.'s stock. Their predictions range from $10.00 to $16.00. On average, they anticipate Anavex Life Sciences Corp.'s stock price to reach $13.67 in the next year.

When will Anavex Life Sciences Corp. announce their earnings?

Anavex Life Sciences Corp. is scheduled to release their next quarterly earnings announcement on Tuesday, May, 9th 2017.

What are analysts saying about Anavex Life Sciences Corp. stock?

Here are some recent quotes from research analysts about Anavex Life Sciences Corp. stock:

  • According to Zacks Investment Research, "ANAVEX LIFE SCIENCES CORP. is an emerging biopharmaceutical company engaged in the discovery and development of novel drug targets for the treatment of cancer and neurological diseases. The company's proprietary SIGMACEPTOR Discovery Platform involves the rational drug design of compounds that fulfill specific criteria based on unmet market needs and new scientific advances. Selected drug candidates demonstrate high, non-exclusive affinity for sigma receptors, which are involved in the modulation of multiple cellular biochemical signaling pathways. " (7/12/2016)

  • FBR & Co analysts commented, "We believe pSivida, a leader in eye drug delivery technology, is making significant progress with regulatory advancement of its eye drug, Medidur, which has already completed one of two planned Phase III studies. In particular, PSDV is on track to file for regulatory approval of Medidur in the EU by year-end. Thus, we think prospects are good for Medidur’s market entry earlier than projected (late 2017 versus our prior estimate of 2018). With the 1Q16 results recently reported by its partner, Alimera Sciences (ALIM), showing sales of Iluvien in diabetic macular edema (DME) accelerated in the first three months of 2016, we believe PSDV has the potential to realize operational break-even results in the next nine to 12 months." (5/12/2016)

Who owns Anavex Life Sciences Corp. stock?

Anavex Life Sciences Corp.'s stock is owned by a number of of institutional and retail investors. Top institutional investors include State Street Corp (0.99%).

Who bought Anavex Life Sciences Corp. stock? Who is buying Anavex Life Sciences Corp. stock?

Anavex Life Sciences Corp.'s stock was purchased by a variety of institutional investors in the last quarter, including State Street Corp.

How do I buy Anavex Life Sciences Corp. stock?

Shares of Anavex Life Sciences Corp. can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Anavex Life Sciences Corp. stock cost?

One share of Anavex Life Sciences Corp. stock can currently be purchased for approximately $5.26.

Anavex Life Sciences Corp. (NASDAQ:AVXL) Chart for Monday, February, 20, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for Anavex Life Sciences Corp. (NASDAQ:AVXL)

Earnings History Chart

Earnings by Quarter for Anavex Life Sciences Corp. (NASDAQ:AVXL)

Dividend History Chart

Dividend Payments by Quarter for Anavex Life Sciences Corp. (NASDAQ:AVXL)

Last Updated on 2/20/2017 by MarketBeat.com Staff